\n| Jebsen granted<\/td>\n | 0<\/td>\n | 0<\/td>\n | 0<\/td>\n | *4<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n * 3 Extensions<\/p>\n The recent review of the applications for small operational funds revealed that application activity could have been better and some does’t revice the small operational funds because they do not seek it elsewhere. <\/span>With the limitations in the allocation of the size we had not enough applications to distribute all the funds and it is probably one application round Number 2 later this year. <\/span>There came no applications from department staff outside Haukeland Campus which possibly means that they are very satisfied or may not read K2news.<\/span><\/p>\nTherefore, it is also this year<\/p>\n \u2022 Sketch Plenary discussions
\n\u2022 Budgeting Help from the administration
\n\u2022 Printing Support from both research advisors and experienced colleagues<\/p>\n To take part in these «support services» it is necessary that applicants comply with deadlines. Participation is also an excellent opportunity to get tested and improved own ideas and help others to improve their applications. To reach up to competition required not only creative ideas, but often also a broad and multi-disciplinary approach to the problem one will resolve and good plans for dissemination and research training. All this can get input and ideas in a structured process where everyone helps each other.<\/p>\n <\/p>\n [:]<\/p>\n","protected":false},"excerpt":{"rendered":" [:no]V\u00e5ren som snart st\u00e5r for d\u00f8ren betyr nye s\u00f8knadsmuligheter, b\u00e5de til forskningsr\u00e5det og andre organisasjoner som Kreftforeningen og Ekstrastiftelsen. I tillegg til FRIMEDBIO har Forskningsr\u00e5det en rekke utlysninger andre utlysninger, blant annet under programmene BEHANDLING og BEDREHELSE som kan v\u00e6re…<\/p>\n Read more →<\/a><\/p>\n","protected":false},"author":3288,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[44,39969],"tags":[],"class_list":["post-11529","post","type-post","status-publish","format-standard","hentry","category-nyheter","category-ukens-leder"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/11529","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/users\/3288"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/comments?post=11529"}],"version-history":[{"count":1,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/11529\/revisions"}],"predecessor-version":[{"id":11530,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/11529\/revisions\/11530"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/media?parent=11529"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/categories?post=11529"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/tags?post=11529"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} |
![\"Ultrafiolett](\"http:\/\/k2info.w.uib.no\/files\/2015\/09\/Ultrafiolett-Eystein1.jpg\")
<\/a>V\u00e5ren som snart st\u00e5r for d\u00f8ren betyr nye s\u00f8knadsmuligheter, b\u00e5de til forskningsr\u00e5det og andre organisasjoner som Kreftforeningen og Ekstrastiftelsen. I tillegg til FRIMEDBIO har Forskningsr\u00e5det en rekke utlysninger andre utlysninger, blant annet under programmene BEHANDLING og BEDREHELSE som kan v\u00e6re relevante for K2-forskere (frist 26.04.2017) Instituttet satser n\u00e5 mye ressurser p\u00e5 forskningsst\u00f8tte blant annet gjennom ansettelsen av v\u00e5re nye forskningsr\u00e5dgivere Itana og fra april Amra Grudic-Feta. De vil v\u00e6re sentrale i s\u00f8knadsprosessene under v\u00e5ren. Som oversikten viser gj\u00f8r K2 gj\u00f8r det jevnt bra selv om det g\u00e5r litt opp og ned – men vi kan alltid strekke oss lenger. Biomedisin hanket in 5 nye fler\u00e5rige prosjekter p\u00e5 FRIMEDBIO i 2016, noe vi kan ha ambisjoner om \u00e5 kopiere.<\/p>\n![\"Ultrafiolett](\"http:\/\/k2info.w.uib.no\/files\/2015\/09\/Ultrafiolett-Eystein.jpg\")
<\/a>Spring will soon stand at the door which means new application opportunities, both for the research council and other organizations as the Cancer Society and Extra Foundation. In addition to FRIMEDBIO Research Council has a number of announcements second announcements, including subprograms TREATMENT and HEALTH that may be relevant for the K2 researchers (deadline 26\/04\/2017) The Department is now concentrating considerable resources on research support including through the appointment of our new research advisers itane and from April Amra Grudic-Feta. They will be key in the application processes during spring. As dashboard displays makes K2 makes it uniformly good although it goes a bit up and down – but we can always reach us anymore. Biomedicine Hanks in 5 new multiannual projects FRIMEDBIO in 2016, something we may have ambitions to copy.<\/p>\n